Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience

Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience

A single-centre retrospective observational study aimed at observing the outcomes of using DEB in ACS patients. All-comer ninety patients were included with a follow-up of 12–36 months. DEBs were deployed successfully yielding TIMI 3 without significant coronary dissection. MACE was 1.1% and 3.3% fo...

Full description

Bibliographic Details
Main Authors: Ahmed Ayuna, Sherif Seif, John MacDonald, Ayyaz Sultan
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Indian Heart Journal
Subjects:
Drug-eluting balloon
Paclitaxel coated balloon
Coronary artery disease
de-novo vessel disease
Acute coronary syndrome
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483221000833
id doaj-70182b63429f4b47a0aa68ce272c0d5a
record_format Article
spelling doaj-70182b63429f4b47a0aa68ce272c0d5a2021-06-21T04:23:23ZengElsevierIndian Heart Journal0019-48322021-05-01733385386Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experienceAhmed Ayuna0Sherif Seif1John MacDonald2Ayyaz Sultan3Cardiology Registrar with Interest in Interventional Cardiology, Salford Royal NHS Foundation Trust, Manchester, UK; Corresponding author. 30 Trippier road, Eccles, Manchester, M30 7PT, UK.Cardiology Clinical Fellow, Royal Albert Edward Infirmary, WWL NHS Trust, Wigan, UKFRCP Consultant Cardiologist Salford Royal NHS Foundation Trust, Manchester, UKFRCP Consultant Cardiologist Royal Albert Edward Infirmary, WWL NHS Trust, Wigan, UKA single-centre retrospective observational study aimed at observing the outcomes of using DEB in ACS patients. All-comer ninety patients were included with a follow-up of 12–36 months. DEBs were deployed successfully yielding TIMI 3 without significant coronary dissection. MACE was 1.1% and 3.3% for 30 days and 12–36 months respectively.http://www.sciencedirect.com/science/article/pii/S0019483221000833Drug-eluting balloonPaclitaxel coated balloonCoronary artery diseasede-novo vessel diseaseAcute coronary syndrome
collection DOAJ
language English
format Article
sources DOAJ
author Ahmed Ayuna
Sherif Seif
John MacDonald
Ayyaz Sultan
spellingShingle Ahmed Ayuna
Sherif Seif
John MacDonald
Ayyaz Sultan
Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience
Indian Heart Journal
Drug-eluting balloon
Paclitaxel coated balloon
Coronary artery disease
de-novo vessel disease
Acute coronary syndrome
author_facet Ahmed Ayuna
Sherif Seif
John MacDonald
Ayyaz Sultan
author_sort Ahmed Ayuna
title Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience
title_short Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience
title_full Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience
title_fullStr Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience
title_full_unstemmed Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience
title_sort short and long terms clinical outcomes of paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: a real world experience
publisher Elsevier
series Indian Heart Journal
issn 0019-4832
publishDate 2021-05-01
description A single-centre retrospective observational study aimed at observing the outcomes of using DEB in ACS patients. All-comer ninety patients were included with a follow-up of 12–36 months. DEBs were deployed successfully yielding TIMI 3 without significant coronary dissection. MACE was 1.1% and 3.3% for 30 days and 12–36 months respectively.
topic Drug-eluting balloon
Paclitaxel coated balloon
Coronary artery disease
de-novo vessel disease
Acute coronary syndrome
url http://www.sciencedirect.com/science/article/pii/S0019483221000833
work_keys_str_mv AT ahmedayuna shortandlongtermsclinicaloutcomesofpaclitaxeldrugelutingballoonsappliedfordenovocoronaryarterylesionsinthecontextofacutecoronarysyndromearealworldexperience
AT sherifseif shortandlongtermsclinicaloutcomesofpaclitaxeldrugelutingballoonsappliedfordenovocoronaryarterylesionsinthecontextofacutecoronarysyndromearealworldexperience
AT johnmacdonald shortandlongtermsclinicaloutcomesofpaclitaxeldrugelutingballoonsappliedfordenovocoronaryarterylesionsinthecontextofacutecoronarysyndromearealworldexperience
AT ayyazsultan shortandlongtermsclinicaloutcomesofpaclitaxeldrugelutingballoonsappliedfordenovocoronaryarterylesionsinthecontextofacutecoronarysyndromearealworldexperience
_version_ 1721369003633410048

Similar Items